{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:38:03Z","timestamp":1777934283711,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>Pipamperon is a potent neuroleptic drug with many side effects, including prolongation of the QT interval. We report a case of a child treated for leukemia in which prolongation of the QT interval was observed. Physicians and pharmacists should be cautious for drug\u2013drug interactions when pipamperon is prescribed, especially in combination with other QT-prolongating agents. Alternative strategies should be used whenever possible.<\/jats:p>","DOI":"10.1177\/1078155217717325","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T13:44:52Z","timestamp":1499780692000},"page":"537-539","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug\u2013drug interaction related to the use of pipamperon and ondansetron in a child treated for leukemia"],"prefix":"10.1177","volume":"24","author":[{"given":"Tiene","family":"Bauters","sequence":"first","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Buts","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Bordon","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Laureys","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"bibr1-1078155217717325","unstructured":"Jibson M. Second-generation antipsychotic medications: pharmacology, administration, and side effects. In: Hermann R (ed.)\n                      UpToDate\n                      . Waltham, MA (accessed 12 January 2017)."},{"key":"bibr2-1078155217717325","unstructured":"Berul C, Seslar P, Zimetbaum P, et\u00a0al. Acquired long QT syndrome. In: Downey B (ed.)\n                      UpToDate\n                      . Waltham, MA (accessed 12 January 2017)."},{"key":"bibr3-1078155217717325","unstructured":"Dipiperon. Summary of product characteristics\n                      , www.bcfi.be (accessed 21 June 2017)."},{"key":"bibr4-1078155217717325","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225040-00004"},{"key":"bibr5-1078155217717325","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192704"},{"key":"bibr6-1078155217717325","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1774"},{"key":"bibr7-1078155217717325","unstructured":"Diagnostic and statistical manual of mental disorders\n                      , www.psychiatry.org\/psychiatrists\/practice\/dsm (accessed 21 June 2017)."},{"key":"bibr8-1078155217717325","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H423"},{"key":"bibr9-1078155217717325","unstructured":"Alizapride. Summary of product characteristics\n                      , www.bcfi.be (accessed 21 June 2017)."},{"key":"bibr10-1078155217717325","unstructured":"Drugbank. Pipamperon\n                      , www.drugbank.ca\/drugs\/DB09286 (accessed 21 June 2017)."},{"key":"bibr11-1078155217717325","unstructured":"VigiAccess\n                      . Uppsala Monitoring Centre, www.vigiaccess.org (accessed 21 June 2017)."},{"key":"bibr12-1078155217717325","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31815d9ae4"},{"key":"bibr13-1078155217717325","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14cr09539"},{"key":"bibr14-1078155217717325","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2011.000397"},{"key":"bibr15-1078155217717325","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-2-46"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155217717325","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155217717325","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155217717325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:17:27Z","timestamp":1777688247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155217717325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1177\/1078155217717325"],"URL":"https:\/\/doi.org\/10.1177\/1078155217717325","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}